MARSHALL KIRSCH

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology FESTUS, MO NPI 1699301549

General Payments — all program years on this page

$982.99

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 57
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $675.80 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $675.8038

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
UCB, Inc. $210.9812
NOVARTIS PHARMACEUTICALS CORPORATION $160.489
JAZZ PHARMACEUTICALS INC. $117.886
Neurelis, Inc. $74.674
EMD Serono, Inc. $59.114
SK Life Science, Inc. $33.832
Acerta Pharma LLC $18.851

By program year

Program yearAmountRecords
2022 $102.426
2023 $204.7713
2024 $675.8038

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087007860 Novartis Pharmaceuticals Corporation $15.80 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087007862 Novartis Pharmaceuticals Corporation $14.97 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087007864 Novartis Pharmaceuticals Corporation $21.97 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087007866 Novartis Pharmaceuticals Corporation $14.15 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087007868 Novartis Pharmaceuticals Corporation $21.03 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087007870 Novartis Pharmaceuticals Corporation $21.48 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087007872 Novartis Pharmaceuticals Corporation $17.53 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087007874 Novartis Pharmaceuticals Corporation $15.69 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087007876 Novartis Pharmaceuticals Corporation $17.86 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110512004 AstraZeneca Pharmaceuticals LP $18.85 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120224729 EMD Serono, Inc. $14.50 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120237312 EMD Serono, Inc. $14.87 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120250441 EMD Serono, Inc. $14.87 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120257420 EMD Serono, Inc. $14.87 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050835 UCB, Inc. $24.65 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050837 UCB, Inc. $21.64 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050839 UCB, Inc. $19.19 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050843 UCB, Inc. $14.27 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050845 UCB, Inc. $15.28 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050847 UCB, Inc. $16.08 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050849 UCB, Inc. $25.90 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050851 UCB, Inc. $0.58 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050853 UCB, Inc. $4.23 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050855 UCB, Inc. $17.15 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050857 UCB, Inc. $32.25 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143050859 UCB, Inc. $19.76 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145645413 Neurelis, Inc. $17.03 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145645415 Neurelis, Inc. $15.71 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145645417 Neurelis, Inc. $25.44 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145645419 Neurelis, Inc. $16.49 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150227965 JAZZ PHARMACEUTICALS INC. $25.42 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150227967 JAZZ PHARMACEUTICALS INC. $16.71 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150227969 JAZZ PHARMACEUTICALS INC. $17.15 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150227971 JAZZ PHARMACEUTICALS INC. $19.34 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150227973 JAZZ PHARMACEUTICALS INC. $19.15 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150227975 JAZZ PHARMACEUTICALS INC. $20.11 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154148653 SK Life Science, Inc. $15.19 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154148663 SK Life Science, Inc. $18.64 08/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.